Patent · US Expired

Compounds that inhibit factor Xa activity

US6794507B2 · kind B2 · utility

5Cited by

0References

19Claims

0Family size

Assignee

Morphochem GmbH · DE

Inventors

Michael W. Cappi · Hersbruck, DE
Thilo Fuchs · Hersbruck, DE
Robert Eckl · Munich, DE
Silke Schabbert · Hersbruck, DE

Key dates

Filing date	Feb 19, 2003
Grant date	Sep 21, 2004
Priority date	—
Expiry date	Feb 19, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, solvate, hydrate or a pharmaceutically acceptable formulation thereof. Those compounds can be used for inhibiting factor Xa and for the prevention and/or treatment of thromboembolic conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.